Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 101793
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.101793
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.101793
Variables | All patients (n = 107) | Propensity-matched patients (n = 94) | ||||||
Total (n = 107) | ICG (n = 47) | Non-ICG (n = 60) | P value | Total (n = 94) | ICG (n = 47) | Non-ICG (n = 47) | P value | |
Sex | 0.235 | 0.789 | ||||||
Male | 83 (77.6) | 39 (83.0) | 44 (73.3) | 77 (81.9) | 39 (83.0) | 38 (80.9) | ||
Female | 24 (22.4) | 8 (17.0) | 16 (26.7) | 17 (18.1) | 8 (17.0) | 9 (19.1) | ||
Age, years | 58.4 (11.1) | 55.2 (12.2) | 61.0 (9.5) | 0.007 | 57.5 (11.1) | 55.2 (12.2) | 59.7 (9.4) | 0.059 |
Hepatitis serology | 0.045 | 0.313 | ||||||
None | 28 (26.2) | 8 (17.0) | 20 (33.3) | 20 (21.3) | 8 (17.0) | 12 (25.5) | ||
HBV | 79 (73.8) | 39 (83.0) | 40 (66.7) | 74 (78.7) | 39 (83.0) | 35 (74.5) | ||
PRE-OP Alb, g/L | 43.0 (3.7) | 43.0 (3.5) | 43.0 (3.9) | 0.959 | 43.0 (3.7) | 43.0 (3.5) | 42.9 (3.9) | 0.934 |
PRE-OP TBil, μmol/L | 11.6 (6.5) | 12.2 (7.7) | 11.1 (5.4) | 0.401 | 11.9 (6.8) | 12.2 (7.7) | 11.6 (5.7) | 0.650 |
PRE-OP ALT, U/L | 26.3 (14.9) | 27.6 (17.5) | 25.3 (12.5) | 0.437 | 26.3 (15.4) | 27.6 (17.5) | 25.1 (12.9) | 0.443 |
PRE-OP AST, U/L | 24.7 (8.3) | 23.4 (6.6) | 25.7 (9.3) | 0.455 | 23.7 (7.0) | 23.4 (6.6) | 24.0 (7.5) | 0.715 |
Tumor location | 0.2 | 0.272 | ||||||
caudal lobe | 2 (1.9) | 1 (2.1) | 1 (1.7) | 2 (2.1) | 1 (2.1) | 1 (2.1) | ||
Left lateral lobe | 8 (7.5) | 6 (12.8) | 2 (3.3) | 8 (8.5) | 6 (12.8) | 2 (4.3) | ||
Left medial lobe | 15 (14.0) | 9 (19.1) | 6 (10.0) | 14 (14.9) | 9 (19.1) | 5 (10.6) | ||
Right anterior lobe | 42 (39.3) | 16 (34.0) | 26 (43.3) | 41 (43.6) | 16 (34.0) | 25 (53.2) | ||
Right posterior lobe | 40 (37.4) | 15 (31.9) | 25 (41.7) | 29 (30.9) | 15 (31.9) | 14 (29.8) | ||
Tumor size, cm | 3.1 (1.6) | 2.9 (1.7) | 3.3 (1.5) | 0.256 | 3.1 (1.6) | 2.9 (1.7) | 3.3 (1.6) | 0.234 |
Tumor amount | 0.282 | 0.212 | ||||||
Single | 97 (90.7) | 41 (87.2) | 56 (93.3) | 85 (90.4) | 41 (87.2) | 44 (93.6) | ||
Multiple | 10 (9.3) | 6 (12.8) | 4 (6.7) | 9 (9.6) | 6 (12.8) | 3 (6.4) | ||
Histological grading | 0.341 | 0.460 | ||||||
I-II | 96 (89.7) | 44 (93.6) | 52 (86.7) | 86 (91.5) | 44 (93.6) | 42 (89.4) | ||
III | 11 (10.3) | 3 (6.4) | 8 (13.3) | 8 (8.5) | 3 (6.4) | 5 (10.6) | ||
Degree of hepatic fibrosis | 0.426 | 0.408 | ||||||
0-III | 57 (53.3) | 23 (48.9) | 34 (56.7) | 50 (53.2) | 23 (48.9) | 27 (57.4) | ||
IV | 50 (46.7) | 24 (51.1) | 26 (43.3) | 44 (46.8) | 24 (51.1) | 20 (42.6) | ||
MVI | 0.146 | 0.298 | ||||||
M0 | 63 (58.9) | 24 (51.1) | 39 (65.0) | 53 (56.4) | 24 (51.1) | 29 (61.7) | ||
M1-2 | 44 (41.1) | 23 (48.9) | 21 (35.0) | 41 (43.6) | 23 (48.9) | 18 (38.3) |
- Citation: Wu WX, Huang MB, Wang MX, Chen LH, Hu B, Ding ZB. Laparoscopic hepatectomy using indocyanine green attenuates postoperative inflammatory response for hepatocellular carcinoma: A propensity score matching analysis. World J Gastrointest Surg 2025; 17(1): 101793
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/101793.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.101793